Meros Investment Management, LP Harvard Bioscience Inc Transaction History

Meros Investment Management, LP

  • $221 Million
  • Q3 2025

A detailed history of Meros Investment Management, LP transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Meros Investment Management, LP holds 918,259 shares of HBIO stock, worth $596,868. This represents 0.18% of its overall portfolio holdings.

Number of Shares
918,259
Previous 919,945 0.18%
Holding current value
$596,868
Previous $404,000 2.48%
% of portfolio
0.18%
Previous 0.21%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$0.4 - $0.57 $674 - $961
-1,686 Reduced 0.18%
918,259 $394,000
Q2 2025

Aug 14, 2025
BUY
$0.28 - $0.69 $35,074 - $86,432
125,265 Added 15.76%
919,945 $404,000
Q1 2025

May 13, 2025
SELL
$0.57 - $2.19 $10,845 - $41,669
-19,027 Reduced 2.34%
794,680 $452,000
Q4 2024

Feb 14, 2025
SELL
$2.02 - $2.82 $40,161 - $56,067
-19,882 Reduced 2.39%
813,707 $1.72 Million
Q3 2024

Nov 18, 2024
SELL
$2.64 - $3.54 $4,287 - $5,748
-1,624 Reduced 0.19%
833,589 $2.24 Million
Q2 2024

Aug 15, 2024
BUY
$2.77 - $4.63 $37,176 - $62,139
13,421 Added 1.63%
835,213 $2.38 Million
Q1 2024

May 15, 2024
BUY
$4.02 - $5.39 $8,208 - $11,006
2,042 Added 0.25%
821,792 $3.48 Million
Q4 2023

Feb 14, 2024
BUY
$4.0 - $5.49 $50,532 - $69,355
12,633 Added 1.57%
819,750 $4.39 Million
Q3 2023

Nov 14, 2023
SELL
$4.0 - $5.82 $23,588 - $34,320
-5,897 Reduced 0.73%
807,117 $3.47 Million
Q2 2023

Aug 11, 2023
SELL
$4.19 - $6.16 $1.3 Million - $1.92 Million
-311,192 Reduced 27.68%
813,014 $4.46 Million
Q1 2023

May 16, 2023
SELL
$2.45 - $4.22 $30,965 - $53,336
-12,639 Reduced 1.11%
1,124,206 $4.72 Million
Q4 2022

Feb 14, 2023
BUY
$2.12 - $2.86 $848,871 - $1.15 Million
400,411 Added 54.37%
1,136,845 $3.15 Million
Q3 2022

Nov 14, 2022
BUY
$2.33 - $3.92 $266,675 - $448,655
114,453 Added 18.4%
736,434 $1.89 Million
Q2 2022

Aug 12, 2022
BUY
$3.28 - $6.42 $316,175 - $618,855
96,395 Added 18.34%
621,981 $2.24 Million
Q1 2022

May 13, 2022
BUY
$5.16 - $7.14 $480,607 - $665,026
93,141 Added 21.54%
525,586 $3.26 Million
Q4 2021

Feb 16, 2022
BUY
$6.37 - $8.18 $2.75 Million - $3.54 Million
432,445 New
432,445 $3.05 Million

Others Institutions Holding HBIO

# of Institutions
65
Shares Held
19.5M
Call Options Held
54K
Put Options Held
0
View Full List

About HARVARD BIOSCIENCE INC

HBIO Quotes by TradingView
  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $27.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Meros Investment Management, LP Portfolio

Follow Meros Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meros Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Meros Investment Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email